Abbott Unveils Breakup, Plans To Settle Alleged Marketing Misdeeds | WAMU 88.5 - American University Radio

NPR : News

Filed Under:

Abbott Unveils Breakup, Plans To Settle Alleged Marketing Misdeeds

Abbott Labs is splitting up. The diversified maker of medical products will become two companies: one focused on brand-name prescription drugs and the second on the other stuff, including medical devices, diagnostic tests and baby formula.

It's a big deal, and Forbes' Matt Herper explains the logic behind it: Investors aren't giving drugmakers much respect, so separating the businesses could give a lift to the future stock of the faster-growing non-drug business.

But there's some other darker news on the drug front that got overshadowed by the company's restructuring. Abbott said it's putting aside $1.5 billion to cover an expected settlement with the federal government of claims that the company went way too far in selling the seizure drug Depakote.

Some former Abbott employees filed a lawsuit, later joined by the feds, that alleges the company promoted Depakote for unapproved uses, such as treatment of Alzheimer's dementia, and that it paid kickbacks to doctors to boost sales.

In a release on company earnings, Abbott disclosed the potential settlement, saying that company expenses now include "$1.5 billion of litigation reserves" related to ongoing settlement discussions related to Depakote.

In an August filing Abbott said:

The United States Department of Justice, through the United States Attorney for the Western District of Virginia, is investigating Abbott's sales and marketing activities for Depakote. The government is seeking to determine whether any of these activities violated civil and/or criminal laws, including the Federal False Claims Act, the Food and Drug Cosmetic Act, and the anti-Kickback Statute in connection with Medicare and/or Medicaid reimbursement to third parties. Discussions are ongoing in an effort to resolve potential civil and criminal claims arising from this matter. Abbott is unable to predict the outcome of this matter or to estimate the range or amount of possible loss and no loss reserves have been recorded for this exposure.

Copyright 2011 National Public Radio. To see more, visit http://www.npr.org/.

NPR

A 'Show Boat' With An Asian-American Cast Hits The Rocks

Racial tensions between blacks and whites are at the heart of the "Ol' Man River" musical. Asian-American actors say it doesn't make sense to get on board.
NPR

Silly, Saucy, Scary: Photos Show The Many Faces Of Ugly Fruit

Wonky produce can take on absurdly entertaining shapes. But one food activist says learning to love these crazy contours is key to stopping mounds of food waste.
NPR

Funding Homeland Security: Where Do We Go From Here?

President Obama late Friday signed a stopgap measure to keep the department running for another week, but the tussle over his executive action on immigration, linked to the funding, is not over yet.
NPR

A Neuroscientist Weighs In: Why Do We Disagree On The Color Of The Dress?

Robert Siegel speaks with Dr. Bevil Conway, a neuroscientist at Wellesley College, about the dress that has the whole Internet asking: What color is it?

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.